000 | 01908 a2200493 4500 | ||
---|---|---|---|
005 | 20250514165003.0 | ||
264 | 0 | _c20040420 | |
008 | 200404s 0 0 eng d | ||
022 | _a0022-1767 | ||
024 | 7 |
_a10.4049/jimmunol.172.2.907 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDolan, Brian P | |
245 | 0 | 0 |
_aInvariant chain and the MHC class II cytoplasmic domains regulate localization of MHC class II molecules to lipid rafts in tumor cell-based vaccines. _h[electronic resource] |
260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cJan 2004 |
||
300 |
_a907-14 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 |
_aAdjuvants, Immunologic _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntigen Presentation _xgenetics |
650 | 0 | 4 |
_aAntigen-Presenting Cells _ximmunology |
650 | 0 | 4 |
_aAntigens, Differentiation, B-Lymphocyte _xbiosynthesis |
650 | 0 | 4 |
_aCancer Vaccines _xgenetics |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 |
_aCytoplasm _xgenetics |
650 | 0 | 4 |
_aDown-Regulation _xgenetics |
650 | 0 | 4 |
_aHistocompatibility Antigens Class II _xbiosynthesis |
650 | 0 | 4 |
_aLymphoma, B-Cell _ximmunology |
650 | 0 | 4 |
_aMembrane Microdomains _xgenetics |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred A |
650 | 0 | 4 | _aMice, Inbred BALB C |
650 | 0 | 4 |
_aProtein Structure, Tertiary _xgenetics |
650 | 0 | 4 |
_aSarcoma _ximmunology |
650 | 0 | 4 | _aSequence Deletion |
650 | 0 | 4 | _aTransfection |
700 | 1 | _aPhelan, Timothy P | |
700 | 1 | _aIlkovitch, Dan | |
700 | 1 | _aQi, Ling | |
700 | 1 | _aWade, William F | |
700 | 1 | _aLaufer, Terri M | |
700 | 1 | _aOstrand-Rosenberg, Suzanne | |
773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 172 _gno. 2 _gp. 907-14 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.4049/jimmunol.172.2.907 _zAvailable from publisher's website |
999 |
_c14436253 _d14436253 |